Realizing Chemotherapy as a Therapeutic Option for Prostate Cancer

Dr. Thomas Buckley (2002 Research Grant)

Although, chemotherapy is a popular cancer therapy, it is not as effective for prostate cancer. Chemotherapy is also harmful to healthy cells. As a result, it is not a popular treatment for prostate cancer. In 2002 we granted Dr. Thomas Buckley funds to research a prostate cancer-specific toxin. His work has been very successful; he has developed a drug called PRX302 which selectively and effectively kills PSA-producing cells without harming other tissues.

The results of the initial study were so encouraging that a company, called Protox Therapeutics, was formed to further develop the idea and hopefully bring the discovery to market. The drug is now in phase II clinical trails.

Donate Now!

Tell Ontario to fund the PSA test


Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Dream car draw a win for all Ontarians affected by prostate cancer

February 22, 2019 – TORONTO, ON – A dream came true today for Harold Mutter (ticket #19273), the lucky winner of a 2018 Acura NSX valued at more than $235,000 - the prize for Prostate Cancer Canada’s seventh Rock the Road Raffle.
More

Researchers discover common markers of tumour hypoxia across 19 cancer types

Landmark pan-cancer study analyzes mutation signatures of low oxygen in more than 8,000 tumours
More

Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More


Click here for news archive